physical therapy and chiropractic pLLC

1 maiden lane, 5th floor
new york, new york 10038

NYS Entity Status
ACTIVE

NYS Filing Date
MAY 07, 2014

NYS DOS ID#
4573222

County
QUEENS

Jurisdiction
NEW YORK

Registered Agent
SPIEGEL & UTRERA, P.A., P.C.
1 MAIDEN LANE, 5TH FLOOR
NEW YORK, NEW YORK, 10038

NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY

Name History
2014 - PHYSICAL THERAPY AND CHIROPRACTIC PLLC









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York
  • Mt. Sinai's new therapy dog is a mutt with a mission
    By Peter D'Amato - Thursday Aug 10, 2017

    Midway through his shift at Mount Sinai’s Kravis Children’s Hospital, the health system’s youngest worker was doing his rounds—on four legs. Professor Bunsen...

    To view the full story, click the title link.

    Source: Crain&apso;s New York Business
  • For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY
    By Ben Fidler - Wednesday Aug 9, 2017

    A drug that actually slows or reverses the brain damage inflicted by Parkinson’s disease, rather than just alleviates its often debilitating symptoms, remains elusive. But Prevail Therapeutics, a startup just launched in New York, has become the latest to try. This morning, the Silverstein Foundation, a nonprofit organization formed by OrbiMed partner Jonathan Silverstein, announced […]

    Source: Xconomy New York
  • Novel leukemia treatment could be 1st US gene therapy
    By Associated Press - Thursday Jul 13, 2017

    A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of Pennsylvania and Novartis Corp. The FDA usually follows recommendations from its expert panels, but isn’t...

    Source: New York Post: News